Welcome to ADF
A mechanism providing affordable access to quality assured essential asthma drugs.
The ADF lowers the cost of essential asthma medicines.
With affordable quality assured medicines and a strategy for management of asthma, more people around the world will be able to manage their asthma.
Global Asthma Report 2011
The Global Asthma Report 2011 shows the tools to manage asthma exist but are not reaching many of the 235 million people affected. To highlight the issues surrounding this major non-communicable disease, The Union and the International Study of Asthma and Allergies in Childhood (ISAAC) have collaborated to produce the Global Asthma Report 2011. This report also highlights the role of the Asthma Drug Facility as a practical solution to the problem of access to medicines. Read more... Press Release and Full Report
For further information, please contact